Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.
Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.
Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
Virtual reality in multiple sclerosis - A systematic review.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
The choroid plexus in health and in disease: Dialogues into and out of the brain.
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis.
White Matter Diseases with Radiologic-Pathologic Correlation.
Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
Role of TGFβ signaling in the pathogenesis of Alzheimer's disease.
Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders.
Deep brain stimulation for the treatment of uncommon tremor syndromes.
Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.
Salt intake in multiple sclerosis: friend or foe?
Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
Multiple sclerosis: Dimethyl fumarate is coming of age.
Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis.
Challenge of phenotype estimation for optimal treatment of Krabbe disease.
Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Capacity for financial decision making in multiple sclerosis.
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Pages
« first
‹ previous
…
789
790
791
792
793
794
795
796
797
…
next ›
last »